{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T18:02:47Z","timestamp":1788458567544,"version":"build-2803163510"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2016,1,29]],"date-time":"2016-01-29T00:00:00Z","timestamp":1454025600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"a Grant-in-Aid for Researchers, Hyogo College of Medicine, 2014"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Vessels"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1007\/s00380-016-0796-z","type":"journal-article","created":{"date-parts":[[2016,1,29]],"date-time":"2016-01-29T03:21:09Z","timestamp":1454037669000},"page":"1826-1833","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Long-term effects of L- and N-type calcium channel blocker on uric acid levels and left atrial volume in hypertensive patients"],"prefix":"10.1007","volume":"31","author":[{"given":"Mitsuru","family":"Masaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiaki","family":"Mano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiyo","family":"Eguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shohei","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masataka","family":"Sugahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Hirotani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Tsujino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Komamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Koshiba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tohru","family":"Masuyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,1,29]]},"reference":[{"key":"796_CR1","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/S0002-9149(02)02864-3","volume":"90","author":"TS Tsang","year":"2002","unstructured":"Tsang TS, Barnes ME, Gersh BJ, Bailey KR, Seward JB (2002) Left atrial volume as a morphophysiologic expression of left ventricular diastolic dysfunction and relation to cardiovascular risk burden. Am J Cardiol 90:1284\u20131289","journal-title":"Am J Cardiol"},{"key":"796_CR2","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jacc.2004.09.054","volume":"45","author":"AM Pritchett","year":"2005","unstructured":"Pritchett AM, Mahoney DW, Jacobsen SJ, Rodeheffer RJ, Karon BL, Redfield MM (2005) Diastolic dysfunction and left atrial volume: a population-based study. J Am Coll Cardiol 45:87\u201392","journal-title":"J Am Coll Cardiol"},{"key":"796_CR3","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/ajh\/5.2.95","volume":"5","author":"B Dahlof","year":"1992","unstructured":"Dahlof B, Pennert K, Hansson L (1992) Reversal of left ventricular hypertrophy in hypertensive patients. A metaanalysis of 109 treatment studies. Am J Hypertens 5:95\u2013110","journal-title":"Am J Hypertens"},{"key":"796_CR4","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1056\/NEJM199111283252206","volume":"325","author":"W Grossman","year":"1991","unstructured":"Grossman W (1991) Diastolic dysfunction in congestive heart failure. N Engl J Med 325:1557\u20131564","journal-title":"N Engl J Med"},{"key":"796_CR5","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1161\/hc1202.105290","volume":"105","author":"MR Zile","year":"2002","unstructured":"Zile MR, Brutsaert DL (2002) New concepts in diastolic dysfunction and diastolic heart failure: part II: causal mechanisms and treatment. Circulation 105:1503\u20131508","journal-title":"Circulation"},{"key":"796_CR6","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1093\/eurjhf\/hfp042","volume":"11","author":"C Bergamini","year":"2009","unstructured":"Bergamini C, Cicoira M, Rossi A, Vassanelli C (2009) Oxidative stress and hyperuricaemia: pathophysiology, clinical relevance, and therapeutic implications in chronic heart failure. Eur J Heart Fail 11:444\u2013452","journal-title":"Eur J Heart Fail"},{"key":"796_CR7","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1097\/HJH.0b013e3283567645","volume":"30","author":"M Takatsu","year":"2012","unstructured":"Takatsu M, Hattori T, Murase T, Ohtake M, Kato M, Nashima K, Nakashima C, Takahashi K, Ito H, Niinuma K, Aritomi S, Murohara T, Nagata K (2012) Comparison of the effects of cilnidipine and amlodipine on cardiac remodeling and diastolic dysfunction in Dahl salt-sensitive rats. J Hypertens 30:1845\u20131855","journal-title":"J Hypertens"},{"key":"796_CR8","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1161\/01.HYP.33.6.1447","volume":"33","author":"K Sakata","year":"1999","unstructured":"Sakata K, Shirotani M, Yoshida H, Nawada R, Obayashi K, Togi K, Miho N (1999) Effects of amlodipine and cilnidipine on cardiac sympathetic nervous system and neurohormonal status in essential hypertension. Hypertension 33:1447\u20131452","journal-title":"Hypertension"},{"key":"796_CR9","first-page":"117","volume":"29","author":"K Sakata","year":"2003","unstructured":"Sakata K, Yoshida H, Tamekiyo H, Obayashi K, Nawada R, Doi O, Mori N (2003) Comparative effect of clinidipine and quinapril on left ventricular mass in mild essential hypertension. Drugs Exp Clin Res 29:117\u2013123","journal-title":"Drugs Exp Clin Res"},{"key":"796_CR10","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1038\/hr.2012.96","volume":"35","author":"T Soeki","year":"2012","unstructured":"Soeki T, Kitani M, Kusunose K, Yagi S, Taketani Y, Koshiba K, Wakatsuki T, Orino S, Kawano K, Sata M (2012) Renoprotective and antioxidant effects of cilnidipine in hypertensive patients. Hypertens Res 35:1058\u20131062","journal-title":"Hypertens Res"},{"key":"796_CR11","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1007\/s00380-013-0386-2","volume":"29","author":"E Oda","year":"2014","unstructured":"Oda E (2014) Serum uric acid is an independent predictor of metabolic syndrome in a Japanese health screening population. Heart Vessels 29:496\u2013503","journal-title":"Heart Vessels"},{"key":"796_CR12","doi-asserted-by":"publisher","DOI":"10.1007\/s00380-015-0668-y","author":"T Kawada","year":"2015","unstructured":"Kawada T, Andou T, Fukumitsu M (2015) Metabolic syndrome showed significant relationship with carotid atherosclerosis. Heart Vessels. doi: 10.1007\/s00380-015-0668-y","journal-title":"Heart Vessels"},{"key":"796_CR13","doi-asserted-by":"crossref","first-page":"470","DOI":"10.3109\/10641963.2012.666600","volume":"34","author":"T Hamada","year":"2012","unstructured":"Hamada T, Yamada K, Mizuta E, Watanabe A, Osaki T, Ishida K, Hasegawa A, Sakata S, Mishima M, Ogino K, Nosaka Y, Miyazaki S, Ohtahara A, Ninomiya H, Kato M, Yoshida A, Taniguchi S, Yamamoto K, Hisatome I (2012) Effects of cilnidipine on serum uric acid level and urinary nitrogen monoxide excretion in patients with hypertension. Clin Exp Hypertens 34:470\u2013473","journal-title":"Clin Exp Hypertens"},{"key":"796_CR14","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0894-7317(89)80013-6","volume":"2","author":"NB Schiller","year":"1989","unstructured":"Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, Gutgesell H, Reichek N, Sahn D, Schnittger I, Silverman N, Tajik A (1989) Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 2:358\u2013367","journal-title":"J Am Soc Echocardiogr"},{"key":"796_CR15","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.echo.2005.10.005","volume":"18","author":"RM Lang","year":"2005","unstructured":"Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ (2005) Recommendations for chamber quantification: a report from the American Society of Echocardiography\u2019s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 18:1440\u20131463","journal-title":"J Am Soc Echocardiogr"},{"key":"796_CR16","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/HJH.0b013e32834103d4","volume":"29","author":"C Yoshida","year":"2011","unstructured":"Yoshida C, Goda A, Naito Y, Nakaboh A, Matsumoto M, Otsuka M, Ohyanagi M, Hirotani S, Lee-Kawabata M, Tsujino T, Masuyama T (2011) Role of plasma aldosterone concentration in regression of left-ventricular mass following antihypertensive medication. J Hypertens 29:357\u2013363","journal-title":"J Hypertens"},{"key":"796_CR17","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.amjcard.2005.05.031","volume":"96","author":"Y Takemoto","year":"2005","unstructured":"Takemoto Y, Barnes ME, Seward JB, Lester SJ, Appleton CA, Gersh BJ, Bailey KR, Tsang TS (2005) Usefulness of left atrial volume in predicting first congestive heart failure in patients\u00a0>\u00a0or\u00a0=\u00a065\u00a0years of age with well-preserved left ventricular systolic function. Am J Cardiol 96:832\u2013836","journal-title":"Am J Cardiol"},{"key":"796_CR18","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.amjcard.2005.07.126","volume":"97","author":"JS Gottdiener","year":"2006","unstructured":"Gottdiener JS, Kitzman DW, Aurigemma GP, Arnold AM, Manolio TA (2006) Left atrial volume, geometry, and function in systolic and diastolic heart failure of persons\u00a0>\u00a0or\u00a0=\u00a065\u00a0years of age (the cardiovascular health study). Am J Cardiol 97:83\u201389","journal-title":"Am J Cardiol"},{"key":"796_CR19","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1161\/CIRCULATIONAHA.110.011031","volume":"124","author":"MR Zile","year":"2011","unstructured":"Zile MR, Gottdiener JS, Hetzel SJ, McMurray JJ, Komajda M, McKelvie R, Baicu CF, Massie BM, Carson PE (2011) Prevalence and significance of alterations in cardiac structure and function in patients with heart failure and a preserved ejection fraction. Circulation 124:2491\u20132501","journal-title":"Circulation"},{"key":"796_CR20","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1161\/01.CIR.89.2.724","volume":"89","author":"SM Vaziri","year":"1994","unstructured":"Vaziri SM, Larson MG, Benjamin EJ, Levy D (1994) Echocardiographic predictors of nonrheumatic atrial fibrillation. The Framingham Heart Study. Circulation 89:724\u2013730","journal-title":"Circulation"},{"key":"796_CR21","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1161\/01.CIR.92.4.835","volume":"92","author":"EJ Benjamin","year":"1995","unstructured":"Benjamin EJ, D\u2019Agostino RB, Belanger AJ, Wolf PA, Levy D (1995) Left atrial size and the risk of stroke and death. The Framingham Heart Study. Circulation 92:835\u2013841","journal-title":"Circulation"},{"key":"796_CR22","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1007\/s11886-012-0268-8","volume":"14","author":"MY Tsang","year":"2012","unstructured":"Tsang MY, Barnes ME, Tsang TS (2012) Left atrial volume: clinical value revisited. Curr Cardiol Rep 14:374\u2013380","journal-title":"Curr Cardiol Rep"},{"key":"796_CR23","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/S0735-1097(03)00956-2","volume":"42","author":"PS Douglas","year":"2003","unstructured":"Douglas PS (2003) The left atrium: a biomarker of chronic diastolic dysfunction and cardiovascular disease risk. J Am Coll Cardiol 42:1206\u20131207","journal-title":"J Am Coll Cardiol"},{"key":"796_CR24","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jacc.2009.07.059","volume":"55","author":"SV Raman","year":"2010","unstructured":"Raman SV (2010) The hypertensive heart. An integrated understanding informed by imaging. J Am Coll Cardiol 55:91\u201396","journal-title":"J Am Coll Cardiol"},{"key":"796_CR25","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.jjcc.2009.05.012","volume":"54","author":"T Kosaka","year":"2009","unstructured":"Kosaka T, Nakagawa M, Ishida M, Iino K, Watanabe H, Hasegawa H, Ito H (2009) Cardioprotective effect of an L\/N-type calcium channel blocker in patients with hypertensive heart disease. J Cardiol 54:262\u2013272","journal-title":"J Cardiol"},{"key":"796_CR26","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0014-2999(01)01067-6","volume":"422","author":"N Kobayashi","year":"2001","unstructured":"Kobayashi N, Mori Y, Mita S, Nakano S, Kobayashi T, Tsubokou Y, Matsuoka H (2001) Effects of cilnidipine on nitric oxide and endothelin-1 expression and extracellular signal-regulated kinase in hypertensive rats. Eur J Pharmacol 422:149\u2013157","journal-title":"Eur J Pharmacol"},{"key":"796_CR27","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1159\/000210396","volume":"30","author":"T Konda","year":"2009","unstructured":"Konda T, Enomoto A, Aritomi S, Niinuma K, Koganei H, Ogawa T, Nitta K (2009) Different effects of L\/N-type and L-type calcium channel blockers on the renin\u2013angiotensin\u2013aldosterone system in SHR\/Izm. Am J Nephrol 30:155\u2013161","journal-title":"Am J Nephrol"},{"key":"796_CR28","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1111\/j.1476-5381.2009.00407.x","volume":"158","author":"A Takahara","year":"2009","unstructured":"Takahara A, Nakamura Y, Wagatsuma H, Aritomi S, Nakayama A, Satoh Y, Akie Y, Sugiyama A (2009) Long-term blockade of L\/N-type Ca(2+) channels by cilnidipine ameliorates repolarization abnormality of the canine hypertrophied heart. Br J Pharmacol 158:1366\u20131374","journal-title":"Br J Pharmacol"},{"key":"796_CR29","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1097\/HJH.0b013e328336ade3","volume":"28","author":"YY Fan","year":"2010","unstructured":"Fan YY, Kohno M, Nakano D, Ohsaki H, Kobori H, Suwarni D, Ohashi N, Hitomi H, Asanuma K, Noma T, Tomino Y, Fujita T, Nishiyama A (2010) Cilnidipine suppresses podocyte injury and proteinuria in metabolic syndrome rats: possible involvement of N-type calcium channel in podocyte. J Hypertens 28:1034\u20131043","journal-title":"J Hypertens"},{"key":"796_CR30","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s00380-011-0191-8","volume":"27","author":"S Aritomi","year":"2012","unstructured":"Aritomi S, Konda T, Yoshimura M (2012) L\/N-type calcium channel blocker suppresses reflex aldosterone production induced by antihypertensive action. Heart Vessels 27:419\u2013423","journal-title":"Heart Vessels"},{"key":"796_CR31","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.bbrc.2013.03.040","volume":"434","author":"M Nishida","year":"2013","unstructured":"Nishida M, Ishikawa T, Saiki S, Sunggip C, Aritomi S, Harada E, Kuwahara K, Hirano K, Mori Y, Kim-Mitsuyama S (2013) Voltage-dependent N-type Ca2+ channels in endothelial cells contribute to oxidative stress-related endothelial dysfunction induced by angiotensin II in mice. Biochem Biophys Res Commun 434:210\u2013216","journal-title":"Biochem Biophys Res Commun"},{"key":"796_CR32","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0895-7061(01)02218-X","volume":"14","author":"JD Lefrandt","year":"2001","unstructured":"Lefrandt JD, Heitmann J, Sevre K, Castellano M, Hausberg M, Fallon M, Fluckiger L, Urbigkeit A, Rostrup M, Agabiti-Rosei E, Rahn KH, Murphy M, Zannad F, de Kam PJ, van Roon AM, Smit AJ (2001) The effects of dihydropyridine and phenylalkylamine calcium antagonist classes on autonomic function in hypertension: the VAMPHYRE study. Am J Hypertens 14:1083\u20131089","journal-title":"Am J Hypertens"},{"key":"796_CR33","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1097\/00004872-200206000-00026","volume":"20","author":"J Struck","year":"2002","unstructured":"Struck J, Muck P, Trubger D, Handrock R, Weidinger G, Dendorfer A, Dodt C (2002) Effects of selective angiotensin II receptor blockade on sympathetic nerve activity in primary hypertensive subjects. J Hypertens 20:1143\u20131149","journal-title":"J Hypertens"},{"key":"796_CR34","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/0735-1097(93)90735-J","volume":"21","author":"RA Nishimura","year":"1993","unstructured":"Nishimura RA, Schwartz RS, Holmes DR Jr, Tajik AJ (1993) Failure of calcium channel blockers to improve ventricular relaxation in humans. J Am Coll Cardiol 21:182\u2013188","journal-title":"J Am Coll Cardiol"},{"key":"796_CR35","doi-asserted-by":"crossref","first-page":"4027","DOI":"10.1016\/j.ijcard.2013.06.067","volume":"168","author":"TF Chao","year":"2013","unstructured":"Chao TF, Hung CL, Chen SJ, Wang KL, Chen TJ, Lin YJ, Chang SL, Lo LW, Hu YF, Tuan TC, Chen SA (2013) The association between hyperuricemia, left atrial size and new-onset atrial fibrillation. Int J Cardiol 168:4027\u20134032","journal-title":"Int J Cardiol"},{"key":"796_CR36","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1183\/09031936.99.13368299","volume":"13","author":"MM Hoeper","year":"1999","unstructured":"Hoeper MM, Hohlfeld JM, Fabel H (1999) Hyperuricaemia in patients with right or left heart failure. Eur Respir J 13:682\u2013685","journal-title":"Eur Respir J"},{"key":"796_CR37","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1001\/jama.300.8.924","volume":"300","author":"DI Feig","year":"2008","unstructured":"Feig DI, Soletsky B, Johnson RJ (2008) Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial. JAMA 300:924\u2013932","journal-title":"JAMA"},{"key":"796_CR38","doi-asserted-by":"crossref","first-page":"7","DOI":"10.7326\/0003-4819-131-1-199907060-00003","volume":"131","author":"BF Culleton","year":"1999","unstructured":"Culleton BF, Larson MG, Kannel WB, Levy D (1999) Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study. Ann Intern Med 131:7\u201313","journal-title":"Ann Intern Med"},{"key":"796_CR39","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1111\/j.1523-1755.2005.00273.x","volume":"67","author":"UM Khosla","year":"2005","unstructured":"Khosla UM, Zharikov S, Finch JL, Nakagawa T, Roncal C, Mu W, Krotova K, Block ER, Prabhakar S, Johnson RJ (2005) Hyperuricemia induces endothelial dysfunction. Kidney Int 67:1739\u20131742","journal-title":"Kidney Int"},{"key":"796_CR40","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1136\/heartjnl-2012-302535","volume":"99","author":"M Kanbay","year":"2013","unstructured":"Kanbay M, Segal M, Afsar B, Kang DH, Rodriguez-Iturbe B, Johnson RJ (2013) The role of uric acid in the pathogenesis of human cardiovascular disease. Heart 99:759\u2013766","journal-title":"Heart"},{"key":"796_CR41","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1093\/rheumatology\/ket444","volume":"53","author":"KL Pan","year":"2014","unstructured":"Pan KL, Lin JC, Lin CL, Chen MC, Chang PJ, Hsiao JF, Chang ST, Chung CM (2014) The effects of gout on left atrial volume remodelling: a prospective echocardiographic study. Rheumatology (Oxford) 53:867\u2013874","journal-title":"Rheumatology (Oxford)"},{"key":"796_CR42","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/s00380-013-0346-x","volume":"29","author":"M Nishino","year":"2014","unstructured":"Nishino M, Mori N, Yoshimura T, Nakamura D, Lee Y, Taniike M, Makino N, Kato H, Egami Y, Shutta R, Tanouchi J, Yamada Y (2014) Higher serum uric acid and lipoprotein(a) are correlated with coronary spasm. Heart Vessels 29:186\u2013190","journal-title":"Heart Vessels"},{"key":"796_CR43","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1161\/01.HYP.0000072820.07472.3B","volume":"41","author":"J Kanellis","year":"2003","unstructured":"Kanellis J, Watanabe S, Li JH, Kang DH, Li P, Nakagawa T, Wamsley A, Sheikh-Hamad D, Lan HY, Feng L, Johnson RJ (2003) Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2. Hypertension 41:1287\u20131293","journal-title":"Hypertension"},{"key":"796_CR44","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1006\/abbi.1999.1491","volume":"372","author":"CX Santos","year":"1999","unstructured":"Santos CX, Anjos EI, Augusto O (1999) Uric acid oxidation by peroxynitrite: multiple reactions, free radical formation, and amplification of lipid oxidation. Arch Biochem Biophys 372:285\u2013294","journal-title":"Arch Biochem Biophys"},{"key":"796_CR45","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0014-5793(99)00231-8","volume":"446","author":"PM Abuja","year":"1999","unstructured":"Abuja PM (1999) Ascorbate prevents prooxidant effects of urate in oxidation of human low density lipoprotein. FEBS Lett 446:305\u2013308","journal-title":"FEBS Lett"},{"key":"796_CR46","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1161\/01.HYP.36.6.1072","volume":"36","author":"P Verdecchia","year":"2000","unstructured":"Verdecchia P, Schillaci G, Reboldi G, Santeusanio F, Porcellati C, Brunetti P (2000) Relation between serum uric acid and risk of cardiovascular disease in essential hypertension. The PIUMA study. Hypertension 36:1072\u20131078","journal-title":"Hypertension"},{"key":"796_CR47","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1253\/circj.CJ-14-1267","volume":"79","author":"S Sugihara","year":"2015","unstructured":"Sugihara S, Hisatome I, Kuwabara M, Niwa K, Maharani N, Kato M, Ogino K, Hamada T, Ninomiya H, Higashi Y, Ichida K, Yamamoto K (2015) Depletion of uric acid due to SLC22A12 (URAT1) loss-of-function mutation causes endothelial dysfunction in hypouricemia. Circ J 79:1125\u20131132","journal-title":"Circ J"},{"key":"796_CR48","doi-asserted-by":"crossref","first-page":"6858","DOI":"10.1073\/pnas.78.11.6858","volume":"78","author":"BN Ames","year":"1981","unstructured":"Ames BN, Cathcart R, Schwiers E, Hochstein P (1981) Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis. Proc Natl Acad Sci USA 78:6858\u20136862","journal-title":"Proc Natl Acad Sci USA"},{"key":"796_CR49","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/00005344-200109000-00005","volume":"38","author":"WS Waring","year":"2001","unstructured":"Waring WS, Webb DJ, Maxwell SR (2001) Systemic uric acid administration increases serum antioxidant capacity in healthy volunteers. J Cardiovasc Pharmacol 38:365\u2013371","journal-title":"J Cardiovasc Pharmacol"},{"key":"796_CR50","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.2337\/db06-0283","volume":"55","author":"WS Waring","year":"2006","unstructured":"Waring WS, McKnight JA, Webb DJ, Maxwell SR (2006) Uric acid restores endothelial function in patients with type 1 diabetes and regular smokers. Diabetes 55:3127\u20133132","journal-title":"Diabetes"},{"key":"796_CR51","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1111\/jch.12412","volume":"16","author":"S Uchida","year":"2014","unstructured":"Uchida S, Takahashi M, Sugawara M, Saito T, Nakai K, Fujita M, Mochizuki K, Shin I, Morita T, Hikita T, Itakura H, Takahashi Y, Mizuno S, Ohno Y, Ito K, Ito T, Soma M (2014) Effects of the N\/L-type calcium channel blocker cilnidipine on nephropathy and uric acid metabolism in hypertensive patients with chronic kidney disease (J-CIRCLE study). J Clin Hypertens (Greenwich) 16:746\u2013753","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"796_CR52","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/hr.2010.191","volume":"34","author":"S Aritomi","year":"2011","unstructured":"Aritomi S, Wagatsuma H, Numata T, Uriu Y, Nogi Y, Mitsui A, Konda T, Mori Y, Yoshimura M (2011) Expression of N-type calcium channels in human adrenocortical cells and their contribution to corticosteroid synthesis. Hypertens Res 34:193\u2013201","journal-title":"Hypertens Res"}],"container-title":["Heart and Vessels"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00380-016-0796-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00380-016-0796-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00380-016-0796-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00380-016-0796-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T11:27:53Z","timestamp":1559042873000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00380-016-0796-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,29]]},"references-count":52,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["796"],"URL":"https:\/\/doi.org\/10.1007\/s00380-016-0796-z","relation":{},"ISSN":["0910-8327","1615-2573"],"issn-type":[{"value":"0910-8327","type":"print"},{"value":"1615-2573","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,29]]}}}